tiprankstipranks
Trending News
More News >

Caroline S Levy Insider Profile

4 Followers
Caroline S Levy, Director at Niagen Bioscience, holds ― shares in Niagen Bioscience (Ticker: NAGE), holds 42.76K shares in Celsius Holdings (Ticker: CELH). Most recently, Caroline S Levy ― shares of Niagen Bioscience on ― for an estimated value of ―.
tipranks
Caroline S Levy

Caroline S Levy
Niagen Bioscience (NAGE)
Director

Ranked #86,136 out of 103,606 Corporate Insiders

Profitable Transactions

50%
2 out of 4 Profitable Transactions

Average Return

-29.90%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$3M
100.00%
0.00%
A breakdown of Caroline S Levy's holdings

Insider Roles

Celsius Holdings
(CELH)
Director
Niagen Bioscience
(NAGE)
Director
Roles that Caroline S Levy holds in companies

Most Profitable Insider Trade

Stock:
Celsius Holdings
(CELH)
Rating:Informative Sell
Date:Mar 14, 2024 - Mar 14, 2025
Return:+71.00%
The most profitable trade made by Caroline S Levy

Caroline S Levy's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Niagen Bioscience
Director
Celsius Holdings
Mar 13, 2025
Director
Uninformative Buy
338.80K
$2.52M
List of latest transactions for each holding click on a transaction to see Caroline S Levy's performance on stock

Caroline S Levy insider profile FAQ

What is the percentage of profitable transactions made by Caroline S Levy?
The percentage of profitable transactions made by Caroline S Levy is 50%.
    What is the average return per transaction made by Caroline S Levy?
    The average return per transaction made by Caroline S Levy is -29.90%.
      What stocks does Caroline S Levy hold?
      Caroline S Levy holds: NAGE, CELH stocks.
        What was Caroline S Levy’s latest transaction?
        Caroline S Levy latest transaction was an Uninformative Buy of ―.
          What was Caroline S Levy's most profitable transaction?
          Caroline S Levy’s most profitable transaction was an Informative Sell of CELH stock on March 14, 2024. The return on the trade was 71.00%.
            What is Caroline S Levy's role in Niagen Bioscience?
            Caroline S Levy's role in Niagen Bioscience is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.